BioSpace News Archive

Dynatronics Corporation, a leading manufacturer of athletic training, physical therapy, and rehabilitation products, announced that the company will release financial results for its fiscal third quarter period ended March 31, 2021 on Thursday, May 13, 2021 before the market opens.

Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to provide a corporate update.

PeriGen, Inc., the market leader in applying artificial intelligence (AI) to improve safety in childbirth, today announced it has been acquired by Halma plc. Based in the UK, Halma is a FTSE 100 global group of life-saving technology companies that provide innovative solutions to many of the key problems facing the world today – such as avoidable adverse events in childbirth.

Elite Pharmaceuticals, Inc., a specialty pharmaceutical company developing and manufacturing niche generic products, announced that Marc Bregman, CPA, has been appointed as Chief Financial Officer, effective May 17, 2021.

Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the launch of a new COVID-19 mouse model.

Patients in areas across the country now have access to Deep Transcranial Magnetic Stimulation (Deep TMS) therapy as an aid for short-term smoking cessation

On April 29, Nephria Bio, a privately held US corporation specializing in the development of innovative approaches to dialysis, announced that it signed a license agreement with Drexel University to transfer technology of new MXene nanomaterials.

Oracle Leader Bob Weiler Joins Board of Directors; Biopharma Market Access and Commercial Expert Dr. Amy Grogg Joins CEO Advisory Board from AmerisourceBergen

Sommetrics is pleased to announce US Food and Drug Administration (FDA) approval of its Investigational Device Exemption (IDE) application to conduct a pivotal in-home clinical trial of its aerSleep II system.

Scientists investigate if City of Hope’s natural supplement derived from white button mushroom could lower prostate-specific antigen levels, an indicator of prostate cancer.